India to Nigeria Pharmaceutical Export (2026) — $592.4M, 616 Suppliers | TransData Nexus

India to Nigeria Pharmaceutical Export (2026) — $592.4M, 616 Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — India to Nigeria

#	Formulation	Value	Share
1	Pharmaceutical Products; Oliclox Capsules Each Capsule Contains: Ampici	$38.6M	6.5%
2	Pretomanid 200mg Tablets (26's) ( Dovprela ) (16646 Packs : 26's Bottle)	$22.5M	3.8%
3	Tramadol Hcl 50mg/ Capsule Sivotram 50	$19.3M	3.3%
4	Tramadol Hcl 100mg/ Capsule Sivotram 100	$16.7M	2.8%
5	Moxifloxacin Hydrochloride 400 MG Tablets. (10x10's) (6466 Pack)	$10.3M	1.7%
6	Azithromycin Oral Suspension 200 Mg/5 ML	$9.7M	1.6%
7	Dtp-hepb-hib (pentavalent Vaccine) Fullyliquid Combination Vaccine 10 Dose Vial…	$8.2M	1.4%
8	Dolutegravir Lamivudine and Tenofovir	$7.3M	1.2%
9	Tramdate Labetalol Hydrochloride Tablets	$7.0M	1.2%
10	Pharmaceutical Products : Tobidex 0.5-dexamethasone Tablets BP 0.5 MG	$6.6M	1.1%
11	Linezolid 600mg Tablets. (10x10's) (2316pack)	$4.9M	0.8%
12	Aceclofenac and Paracetamol Tablets ( Ac	$4.2M	0.7%
13	H/m-amodiaquine 150mg +sulfadoxine/pyrimethamine 500/25mg Dispersible Tablets (…	$3.6M	0.6%
14	Moxifloxacin Hydrochloride 400mg Tablets. (10x10's) (2187 Pack)	$3.5M	0.6%
15	Human Pharmaceuticals Formulation Nutrac	$3.5M	0.6%

India exports 20+ pharmaceutical formulations to Nigeria with a combined trade value of $592.4M. Key products include Tramadol ($19.3M), Moxifloxacin ($10.3M), Azithromycin ($9.7M), Dolutegravir ($7.3M), Linezolid ($4.9M). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 19,201 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — India to Nigeria Trade Routes

1Tramadol$19.3M 2Moxifloxacin$10.3M 3Azithromycin$9.7M 4Dolutegravir$7.3M 5

Top Indian Exporters to Nigeria

1Maxheal Pharmaceuticals (india) Limited

$44.7M

2Saga Lifesciences Limited

$43.6M

3Mylan Laboratories Limited

$30.5M

4Macleods Pharmaceuticals Ltd

$27.8M

5Lincoln Pharmaceuticals Ltd

Port Analysis — India to Nigeria Pharmaceutical Shipments

Indian Export Ports

NHAVA SHEVA SEA (INNSA1)13.5%

AHEMDABAD ICD2.4%

NHAVA SHEVA SEA1.0%

DELHI AIR7.3%

JNPT6.6%

Nigeria Import Ports

Apapa27.3%

APAPA23.1%

LAGOS31.1%

Lagos3.4%

ABUJA3.6%

Trade Statistics

Total Value$592.4M

Shipments19,201

Indian Exporters616

Nigeria Buyers1412

Avg Shipment$31K

Products12,918

Other Destinations

United States$8.8B United Kingdom$1.2B Canada$1.1B

Last updated: March 28, 2026

India–Nigeria Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The India-Nigeria pharmaceutical trade corridor has experienced significant growth over the past two decades. In 2024, India exported pharmaceutical products valued at $449.07 million to Nigeria, marking a substantial increase from previous years. This growth is attributed to India's competitive pricing, adherence to WHO-GMP standards, and a diverse product portfolio. The trade relationship has been further bolstered by Nigeria's increasing demand for affordable and quality medicines to address its healthcare challenges.

Key milestones include the establishment of direct shipping routes and the facilitation of regulatory processes, which have streamlined the export of pharmaceutical formulations. The presence of Indian pharmaceutical companies in Nigeria has also enhanced market penetration, contributing to the strengthening of bilateral trade ties.

2India's Market Position

India holds a dominant position in Nigeria's pharmaceutical import market, accounting for a significant share compared to other origins. This dominance is due to India's ability to supply a wide range of finished pharmaceutical formulations that meet international quality standards at competitive prices. The strategic importance of this market is underscored by India's focus on expanding its footprint in Africa, with Nigeria serving as a key entry point.

The Indian government's initiatives to promote pharmaceutical exports, coupled with the industry's capacity to produce large volumes of generic medicines, have solidified India's standing as a preferred supplier to Nigeria.

Nigeria Regulatory Landscape for Indian Pharmaceutical Exports

Registration process, GMP requirements, import documentation

1Registration Process

To register pharmaceutical products in Nigeria, Indian companies must submit a comprehensive Common Technical Document (CTD) dossier to NAFDAC. The dossier should include administrative, quality, non-clinical, and clinical data. Upon submission, NAFDAC conducts a document verification process, followed by facility inspection and laboratory analysis. The entire registration process typically takes up to 240 working days from the acceptance of the application. (nafdac.gov.ng)

For products prequalified by the World Health Organization (WHO), NAFDAC offers an accelerated registration procedure, reducing the processing time. This pathway is particularly beneficial for Indian manufacturers with WHO-prequalified products, as it expedites market entry into Nigeria. (nafdac.gov.ng)

2GMP & Facility Requirements

NAFDAC requires that manufacturing facilities comply with Good Manufacturing Practice (GMP) standards as outlined by the World Health Organization. Indian pharmaceutical companies must provide evidence of GMP compliance, which may include certificates from recognized authorities. NAFDAC conducts inspections to verify adherence to these standards. The agency also considers mutual recognition agreements, which can simplify the inspection process for manufacturers with existing certifications from other recognized bodies. (nafdac.gov.ng)

3Import Documentation

When exporting pharmaceutical products to Nigeria, Indian companies must ensure that all necessary import documentation is in order. This includes obtaining an import license, providing a Certificate of Pharmaceutical Product (CPP), a Certificate of Analysis (CoA), and evidence of GMP compliance. Customs procedures require that these documents accompany shipments to facilitate clearance. Additionally, NAFDAC may require pre-shipment inspection and testing to verify product quality before importation. (nafdac.gov.ng)

TransData Nexus Research · Nigeria regulatory databasesMar 2026

FAQ — India to Nigeria Pharmaceutical Trade

What is the total value of India's pharmaceutical export to Nigeria?

India exported pharmaceuticals worth $592.4M to Nigeria across 19,201 verified shipments.

Who are the top Indian pharmaceutical exporters to Nigeria?

1. MAXHEAL PHARMACEUTICALS (INDIA) LIMITED — $44.7M. 2. SAGA LIFESCIENCES LIMITED — $43.6M. 3. MYLAN LABORATORIES LIMITED — $30.5M. Total: 616 suppliers.

Which companies in Nigeria import pharmaceuticals from India?

1. CUS PHARMACEUTICALS AND CHEMICAL CO — $39.8M. 2. ADPHARM, PHARMACEUTICAL INDUSTRIES — $36.1M. 3. NATIONAL TUBERCULOSIS AND LEPROSY — $27.8M. 1412 buyers total.

What pharmaceutical products does India export most to Nigeria?

1. Pharmaceutical Products; Oliclox Capsules Each Capsule Contains: Ampici ($38.6M, 6.5%); 2. Pretomanid 200mg Tablets (26's) ( Dovprela ) (16646 Packs : 26's Bottle) ($22.5M, 3.8%); 3. Tramadol Hcl 50mg/ Capsule Sivotram 50 ($19.3M, 3.3%); 4. Tramadol Hcl 100mg/ Capsule Sivotram 100 ($16.7M, 2.8%); 5. Moxifloxacin Hydrochloride 400 MG Tablets. (10x10's) (6466 Pack) ($10.3M, 1.7%)

Which ports handle pharmaceutical shipments from India to Nigeria?

Export: NHAVA SHEVA SEA (INNSA1), AHEMDABAD ICD, NHAVA SHEVA SEA, DELHI AIR, JNPT. Import: Apapa, APAPA, LAGOS, Lagos, ABUJA.

Why does Nigeria import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $592.4M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Nigeria?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Nigeria pharmaceutical trade?

$30.9K per consignment across 19,201 shipments.

How many Indian pharmaceutical companies export to Nigeria?

616 Indian companies. Largest: MAXHEAL PHARMACEUTICALS (INDIA) LIMITED with $44.7M.

How can I find verified Indian pharmaceutical suppliers for Nigeria?

TransData Nexus covers 616 active exporters with shipment history and trade values at transdatanexus.com.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Nigeria identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 19,201 verified shipments from 616 Indian exporters to 1412 Nigeria buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

616 Exporters

1412 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

India to Nigeria Pharmaceutical Export

Top Pharmaceutical Formulations — India to Nigeria

Top Pharmaceutical Products — India to Nigeria Trade Routes

Top Indian Exporters to Nigeria

Port Analysis — India to Nigeria Pharmaceutical Shipments

Indian Export Ports

Nigeria Import Ports

Trade Statistics

Other Destinations

India–Nigeria Pharmaceutical Trade Corridor Analysis

1Trade Corridor Evolution

2India's Market Position

Top Nigeria Buyers from India

Product Routes

Full Dataset Access

3Recent Developments

Nigeria Regulatory Landscape for Indian Pharmaceutical Exports

1Registration Process

2GMP & Facility Requirements

3Import Documentation

Product Categories & Therapeutic Trends — India to Nigeria

1Dominant Categories

2Emerging Opportunities

3Demand Drivers

Trade Policy & Tariff Intelligence — India and Nigeria

1Tariff & Duty Structure

2Trade Agreements

3IP & Patent Landscape

Supply Chain & Logistics — India to Nigeria Pharma Shipments

1Shipping Routes & Transit

2Port Infrastructure

3Cold Chain & Compliance

Market Opportunity Assessment — Nigeria for Indian Pharma

1Market Size & Growth

2Healthcare System

3Opportunity for Indian Exporters

Competitive Landscape — India vs Other Pharmaceutical Suppliers to Nigeria

1Competing Origins

2India's Competitive Edge